These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3718851)

  • 21. The role of anthralin in mouse skin tumour promotion.
    Boutwell RK; Hoel MJ; Digiovanni J
    Br J Dermatol; 1981 Aug; 105 Suppl 20():68-9. PubMed ID: 7284270
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of dithranol on epidermal proliferation by urea modification].
    Wohlrab W
    Dermatol Monatsschr; 1985; 171(2):85-90. PubMed ID: 3979627
    [No Abstract]   [Full Text] [Related]  

  • 23. Ingram method: the precursor of photochemotherapy.
    Raab WP
    Br J Dermatol; 1981 Aug; 105 Suppl 20():77-81. PubMed ID: 7284273
    [No Abstract]   [Full Text] [Related]  

  • 24. On the interaction between anthralin and DNA: a revision.
    Caron JC; Eustache J; Shroot B; Prota G
    Arch Dermatol Res; 1982; 274(3-4):207-12. PubMed ID: 7165372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
    Kersey P; Chapman P; Rogers S; Rawlins M; Shuster S
    Br J Dermatol; 1981 Aug; 105 Suppl 20():64-7. PubMed ID: 6456755
    [No Abstract]   [Full Text] [Related]  

  • 26. Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB).
    Rees JL; Friedmann PS; Matthews JN
    Br J Dermatol; 1989 Mar; 120(3):371-4. PubMed ID: 2713257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disappearance of psoriactic lesions under the effect of anthralin].
    Chowaniec O
    Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
    [No Abstract]   [Full Text] [Related]  

  • 28. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
    Czernielewski J; Juhlin L; Shroot S; Brun P
    Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: anthralin--the challenge.
    Shroot B; Schaefer H; Juhlin L; Greaves MW
    Br J Dermatol; 1981 Aug; 105 Suppl 20():3-5. PubMed ID: 7284261
    [No Abstract]   [Full Text] [Related]  

  • 30. [Side effects of anthralin and its 2 main impurities on healthy skin].
    Puschmann M; Schmersahl P
    Z Hautkr; 1983 Mar; 58(6):410-6. PubMed ID: 6857758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of cignolin and infrared irradiation on the patch test and lymphocyte transformation test].
    Eter J; Schulze HJ; Mahrle G
    Z Hautkr; 1990 Sep; 65(9):807-10, 813-4. PubMed ID: 2264370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of soybean lipoxygenase-1 by 10-butyryl substituted 1,8-dihydroxy-9-anthrone (butantrone).
    Laakso S; Römer L; Mustakallio KK
    Med Biol; 1986; 64(1):43-5. PubMed ID: 3088340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
    Kunze J; Petres J
    Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
    Schallreuter KU; Pittelkow MR
    Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anthralin on mitochondrial and nuclear functions in yeast cells.
    Zetterberg G
    Br J Dermatol; 1981 Aug; 105 Suppl 20():39-42. PubMed ID: 7025882
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of UV-induced DNA repair at different steps by quinacrine and anthralin.
    Kulkarni MS; Yielding KL
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1531-7. PubMed ID: 697879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.